iBio

$0.77

-4.9% today

Market cap

$49M

P/E (trailing)

—

30 days

-34.7%

90 days

-45.0%

1 year

-50.3%

Price · daily close

1M 3M 6M 1Y

Oct 31, 2025May 4Oct 30

iBio, Inc. is a biotech company. The Company develops next-generation biopharmaceuticals for cardiometabolic, obesity, cancer and other hard-to-treat diseases through AI and advanced computational biology. iBio…

News, deals & research about iBio

Latest in AI

Nothing tagged yet, items mentioning iBio will appear here as the desk publishes them.

Prices are daily closes from the AI Lounge market update; not investment advice.

Members see AI Stocks and the AI Lounge Index, prices, market caps, P/E and returns for the whole public AI trade, free.

Create my free account →Log in